Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Bacterial resistance and excessive inflammation are common issues that hinder wound healing. Antimicrobial peptides (AMPs) offer a promising and versatile antibacterial option compared to traditional antibiotics, with additional anti-inflammatory properties. However, the applications of AMPs are limited by their antimicrobial effects and stability against bacterial degradation. TFNAs are regarded as a promising drug delivery platform that could enhance the antibacterial properties and stability of nanodrugs. Therefore, in this study, a composite hydrogel (HAMA/t-GL13K) was prepared via the photocross-linking method, in which tFNAs carry GL13K. The hydrogel was injectable, biocompatible, and could be instantly photocured. It exhibited broad-spectrum antibacterial and anti-inflammatory properties by inhibiting the expression of inflammatory factors and scavenging ROS. Thereby, the hydrogel inhibited bacterial infection, shortened the wound healing time of skin defects in infected skin full-thickness defect wound models and reduced scarring. The constructed HAMA/tFNA-AMPs hydrogels exhibit the potential for clinical use in treating microbial infections and promoting wound healing.

Free full text 


Logo of intjosLink to Publisher's site
Int J Oral Sci. 2024; 16: 30.
Published online 2024 Apr 16. https://doi.org/10.1038/s41368-024-00290-3
PMCID: PMC11018755
PMID: 38622128

Tetrahedral framework nucleic acids/hyaluronic acid-methacrylic anhydride hybrid hydrogel with antimicrobial and anti-inflammatory properties for infected wound healing

Associated Data

Supplementary Materials

Abstract

Bacterial resistance and excessive inflammation are common issues that hinder wound healing. Antimicrobial peptides (AMPs) offer a promising and versatile antibacterial option compared to traditional antibiotics, with additional anti-inflammatory properties. However, the applications of AMPs are limited by their antimicrobial effects and stability against bacterial degradation. TFNAs are regarded as a promising drug delivery platform that could enhance the antibacterial properties and stability of nanodrugs. Therefore, in this study, a composite hydrogel (HAMA/t-GL13K) was prepared via the photocross-linking method, in which tFNAs carry GL13K. The hydrogel was injectable, biocompatible, and could be instantly photocured. It exhibited broad-spectrum antibacterial and anti-inflammatory properties by inhibiting the expression of inflammatory factors and scavenging ROS. Thereby, the hydrogel inhibited bacterial infection, shortened the wound healing time of skin defects in infected skin full-thickness defect wound models and reduced scarring. The constructed HAMA/tFNA-AMPs hydrogels exhibit the potential for clinical use in treating microbial infections and promoting wound healing.

Subject terms: Infectious diseases, Nanostructures

Introduction

Oral and maxillofacial soft tissue trauma is a common condition in the maxillofacial emergency department, with the characteristics of high morbidity, infection rate, and medical cost.1,2 The risk of maxillofacial soft tissue trauma infection is high due to the exposure of maxillofacial skin and the abundance of bacteria in the oral cavity.3 Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) are bacterial species commonly detected in skin wounds.4 And the microbial bioburden is thought to contribute to chronic wound healing impairment.5 Mechanical debridement, layered suturing, prophylactic use of antibiotics and scar removal, including laser therapy, ointment, and micro-needling, are currently common clinical treatments for patients with maxillofacial soft tissue trauma.68 Yet the frequent use of antibiotics may cause resistance.9 Therefore, wound dressing materials such as hydrogels, polyurethane dressings, and silicon dressings have been developed to accelerate wound healing, through pathways including preventing secondary infections, removing wound exudate, and boosting tissue regeneration.

Hydrogel, a crosslinked network of highly hydrophilic polymers, can be a promising wound dressing material for promoting wound healing,10 due to its high-water content, good biocompatibility, and flexibility that is very similar to that of tissue structure.11 One specific type of hydrogel, hyaluronic acid methacrylate (HAMA) hydrogel has advantages such as flexibility and spatiotemporal control of formation, making it suitable for skin tissue engineering.1214 The chemical method of producing HAMA hydrogel has several benefits, including good reaction kinetics, strong mechanical properties, ease of in situ polymerization, and favorable drug loading conditions.15 To endow hydrogel with antimicrobial properties, it is demanded to select and incorporate proper antimicrobial agents into the hydrogel.

Antimicrobial peptides (AMPs) are an intriguing potential replacement to traditional small molecule drugs due to their broad antimicrobial activity and ability to target both Gram-positive and Gram-negative bacteria.16 AMP can bind to the bacterial inner membrane, causing peptide penetration, bacterial cell content leakage, and cell death.17 However, using natural AMP directly as potential therapeutics is not ideal due to the need for relatively high concentrations to achieve effective antimicrobial effects, as well as the cytotoxic effects exhibited at those concentrations.18,19 Meanwhile, biological factors such as alterations in environmental pH and the presence of proteases capable of damaging candidate peptides may have an impact on AMP stability and bioavailability.20,21 Thus, various strategies have been developed to improve the stability and biosafety of natural AMPs while retaining their antibacterial properties.2226 For example, Conjugating AMPs to gold nanoparticles is one of those strategies, which may help to improve enzymatic stability and antimicrobial efficiency.27 The antimicrobial peptide GL13K was derived from the salivary protein BPIFA2 and optimized to provide potent bactericidal, anti-biofilm, and anti-lipopolysaccharide activity against Gram-negative and Gram-positive bacteria.23 However, similar to other AMP, GL13K is susceptible to the aforementioned common issues. For example, GL13K is sensitive to protease produced by Porphyromonas gingivalis (P. gingivalis), one of the pathogenic bacterium of periodontitis.28 In a previous study, Liu et al. utilized tetrahedral framework nucleic acid (tFNAs) as a nano-delivery material for GL13K, improving both its stability and antibacterial efficacy against E. coli and P. gingivalis, and resolved potential issues associated with the direct use of GL13K successfully,25 which suggests a wide range of potential applications for tFNA-based AMP delivery.

TFNAs refer to nucleic-acid materials that are simple to synthesize via self-assembling and utilize widely due to the biological nature of nucleic acids.29 TFNA has several biological attributes in addition to serving as a drug delivery carrier via mechanisms like intercalation, electrostatic interaction, and chemical cross-linking.30 TFNAs have capability to scavenge ROS to realize anti-inflammatory and antioxidant activities.31 In addition, tFNAs in proper size could effectively reach dermis layer transdermal with structural integrity maintained.32 The exquisite designed dynamic structures of TDN size, tailored to specific materials, demonstrated promising potential for targeted and effective antitumor and anti-inflammatory treatment both in vitro and in vivo.3335 Furthermore, tFNAs could contribute to skin wound healing and lessen the formation of scars in vivo.36

In this study, we demonstrate the strategy utilizing HAMA hydrogel to deliver tFNA-loaded antimicrobial peptide GL13K to achieve local antibacterial and anti-inflammatory activity. The novel nanoparticles formed by tFNA and GL13K (tFNA-GL13K) is designed to treat infectious skin wound by promoting cell migration, scavenging ROS and performing anti-inflammatory property. To the best of our knowledge, we firstly reported the cooperation of hydrogels and tFNAs-based composites in infected disease.

Results

Characterization of tFNA and tFNA-GL13K

The synthesis process of t-GL13K was shown in the diagrammatic sketch (Fig. (Fig.1a).1a). In brief, tFNA was synthesized by 4 ssDNA, and then tFNA and GL13K were compounded by electrostatic adsorption for the acquisition of t-GL13K. 8% polyacrylamide gel electrophoresis (PAGE) showed that tFNA migrated at a lower speed than S1-4 ssDNA and other combinations of them, and as the proportion of GL13K increased, the t-GL13K migrated at a lower speed than tFNA and the mass of t-GL13K increased, confirming the successful synthesis of tFNA and t-GL13K. When it exceeds the carrying capability of tFNA, t-GL13K would not form bands on the PAGE. Considering the above principles and the PAGE analysis, the optimal ratio of tFNA to GL13K was determined to be approximately 1:500 (Fig. (Fig.1b).1b). Consequently, the subsequent experiments were conducted with a molecular ratio of 1:500 for tFNA to GL13K in tFNA-GL13K. The triangular geometrical structure of tFNA and t-GL13K were displayed by atomic force microscopy (AFM) (Fig. (Fig.1d)1d) and transmission electron microscopy (TEM) (Fig. (Fig.1e)1e) results. According to the results of the ζ distribution, the ζ potential of tFNA was approximately -9 mV, and the particle size of tFNA was 11 nm approximately. Regarding t-GL13K, the particle size and the complex’s negative charge ranged along with the GL13K ratio altered, which indicated that t-GL13K was successfully synthesized (Fig. (Fig.1c1c).

An external file that holds a picture, illustration, etc.
Object name is 41368_2024_290_Fig1_HTML.jpg

Preparation and characterization of HAMA/tFNA-GL13K hydrogel. a Schematic diagram of the preparation of HAMA/tFNA-GL13K hydrogel. b Analysis of Polypropylene Acyl Amine Gel Electrophoresis (PAGE) showed the effective synthesis of tFNA and tFNA-GL13K with the appropriate tFNA/GL13K ratio. c Particle size measurement by DLS and ζ potential measurement by ELS of tFNA and t-GL13K. d Atomic force microscopy evaluation. Scale bars = 500 nm. e TEM images of tFNA (yellow triangles) and tFNA-GL13K (red triangles). Scale bar = 100 nm. f Optical photos of the hydrogel before and after photocuring. g SEM images demonstrating the porous structure of hydrogel. Scale bar = 1 mm (white) and 300 μm (orange). h Attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) of HAMA and HAMA/tFNA-GL13K hydrogel. i Variations of the storage modulus (G′) and the loss modulus (G″) with oscillation frequency of the hydrogels. T-GL13K is the abbreviation of tFNA-GL13K

Characterization of HAMA/tFNA-GL13K hydrogel

As shown in Fig. Fig.1f,1f, the HAMA, HAMA/tFNA, HAMA/GL13K, and HAMA/tFNA-GL13K hydrogel were initially in a liquid state and appeared transparent before photocuring. After photocuring (UV light, 365 nm), the hydrogel underwent a transformation into a semisolid gel. SEM was used to examine the multiporous structure of hydrogels’ surface (Fig. (Fig.1g).1g). As displayed, the pore sizes of HAMA/tFNA, HAMA/ GL13K, and HAMA/tFNA-GL13K hydrogels ranged from 120 to 200 μm. This demonstrated that the HAMA/tFNA-GL13K hydrogels possess suitable pore sizes that facilitate nutrient exchange and cell migration.

The composition of composite hydrogels was analyzed using attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR). By comparing the characteristic peaks of HAMA and HAMA/tFNA-GL13K hydrogels, the presence of each polymer can be confirmed. Figure Figure1h1h shows the ATR-FTIR spectra of the initial materials and the identification of characteristic peaks. The wide peak near 3 380 cm1 corresponds to HAMA, and the sharp peak at 1 600–1 700 cm−1 corresponds to GL13K (the C═O of the amide functional group). The peak at 1 100 cm1 is associated with tFNA, as the infrared absorption bands of DNA include the phosphate symmetric stretching vibration, as shown in Fig. Fig.1h1h.

Rheological analysis was carried out at various frequencies to determine the mechanical properties of hydrogels (Fig. (Fig.1i).1i). Notably, the storage modulus (G′) was found to be larger than the loss modulus (G″), which is a remarkable feature of gels. Compared to other hydrogels, HAMA/tFNA-GL13K hydrogel exhibited a higher storage modulus (G’), indicating a stronger capacity for shape retention. The loss modulus (G″) of the HAMA/tFNA-GL13K hydrogel was midway between the two other hydrogels, indicating a medium strength of viscosity.

The combination of HAMA/tFNA-GL13K appears an effective antibacterial impact

HAMA and HAMA/tFNA hydrogel had virtually no inhibiting impact on the growth of S. aureus and E. coli, as demonstrated in Fig. Fig.2a,2a, b. However, both the HAMA/GL13K and HAMA/tFNA-GL13K hydrogels exhibited bacteriostatic properties, with the colony count of HAMA/tFNA-GL13K group being lower than that of HAMA/GL13K. To investigate the hydrogels’ antibacterial activity against common infectious bacteria, growth curves were measured. Both S. aureus and E. coli showed inhibited growth in the presence of HAMA/GL13K and HAMA/tFNA-GL13K, with HAMA/tFNA-GL13K having the strongest inhibitory ability (Fig. (Fig.2c).2c). In summary, the HAMA/tFNA-GL13K hydrogel revealed potent antibacterial properties against both Gram-positive and Gram-negative bacteria, and the presence of tFNAs enhanced the antibacterial ability of GL13K.

An external file that holds a picture, illustration, etc.
Object name is 41368_2024_290_Fig2_HTML.jpg

Antimicrobial activity of HAMA/tFNA-GL13K hydrogel on E. coli and S. aureus in vitro. a Images of E. coli and S. aureus incubated on agar plates with different hydrogels. b Count bacteria of CFU of E. coli and S. aureus. Superscripts ad indicate significant differences for CFU between different treatment groups (P < 0.05). c Growth curves of E. coli and S. aureus in different hydrogels treatment. n = 3 independent samples. Data are presented as mean ± SD. Error bars represent SD. T-GL13K is the abbreviation of tFNA-GL13K

Distribution of t-GL13K in HaCaT cells

Confocal fluorescence microscopy was used to observe the cellular distribution. It was observed that GL13K was primarily found in the extracellular mesenchyme. The phalloidin-stained cytoskeleton was distinguished from GL13K labeled with fluorescein isothiocyanate (FITC) by coloring the GL13K-FITC channel yellow after confocal fluorescence image capture (Fig. (Fig.3a).3a). Fluorescently labeled tFNAs and GL13K were used to investigate the potential effects of GL13K adsorption on the distribution of tFNAs and vice versa. Flow cytometric analysis was applied to ascertain the cellular distribution of t-GL13K. After 6 h of treatment, both simplex GL13K and t-GL13K had high cellular uptake and fluorescence intensity. The cellular distribution of tFNAs was significantly altered by GL13K adsorption at 6 h (Fig. (Fig.3b3b).

An external file that holds a picture, illustration, etc.
Object name is 41368_2024_290_Fig3_HTML.jpg

The distribution of tFNA-GL13K in HaCaT cells. a Distribution of Cy5-tFNAs, FITC-GL13K and Cy5- FITC-t-GL13K complex in HaCaT cells (Cy5: tFNAs: red; FITC: yellow; nucleus: blue; cytoskeleton: green). Scale bars = 20 μm. b Flow cytometric analysis of distribution of Cy5-tFNAs, FITC-GL13K and Cy5- FITC-t-GL13K complex in HaCaT cells. Superscripts ad indicating significant differences (P < 0.05)

tFNA-GL13K promoted the proliferation and migration of HaCaTs

There was no statistical difference in cell proliferation of HaCaT cells after 6, 12, and 24 h of treatment between the HAMA/tFNA, HAMA/tFNA-GL13K and control groups (Fig. (Fig.4a).4a). The cytotoxicity of the LPS and HAMA/GL13K groups was significantly higher than the other groups, indicating that HAMA/tFNA and HAMA/tFNA-GL13K can alleviate the inhibition of cell proliferation caused by LPS, and the presence of tFNA can reduce cytotoxicity of GL13K. The wound-healing assay was applied to evaluate the effects of t-GL13K on the migratory activities of HaCaT cells. With the presence of LPS, the LPS and HAMA/GL13K groups significantly inhibited HACAT cell migration, whereas the HAMA/tFNA and HAMA/tFNA-GL13K groups promoted single-layer wound closure of scratched HACAT cells (Fig. (Fig.4b).4b). It was demonstrated that the presence of tFNAs could promote cell migration and reduce inhibition of LPS and GL13K.

An external file that holds a picture, illustration, etc.
Object name is 41368_2024_290_Fig4_HTML.jpg

The effect of HAMA/tFNA-GL13K hydrogel on the biological behavior of HaCaT cells. a CCK-8 assays to detect the cytotoxicity of hydrogels on HaCaT cells. Superscripts ad indicating significant differences (P < 0.05). b Images of scratch tests on HaCaT cells treated with different hydrogels at 0 h, 4 h, 8 h, 12 h and 24 h. Scale bars = 200 μm. Statistical analysis of scratch tests was marked with superscripts ae indicating significant differences (P < 0.05). c Quantification of ROS in HaCaT cells. d Quantification of expression of inflammatory factors (IL-1β, IL-G, TNF-α, and p65) in HaCaT cells. Superscripts ae indicating significant differences (P < 0.05). Data are presented as the mean ± SD (n = 3). T-GL13K is the abbreviation of tFNA-GL13K

tFNA-GL13K inhibits the production of ROS and inflammatory factors

LPS is a well-known stimulator of ROS production that leads to inflammation. We investigated the potential influence of HAMA/tFNA-GL13K on LPS-stimulated ROS generation in HaCaT cells. Flow cytometric analysis of ROS levels revealed that HAMA/tFNA and HAMA/tFNA-GL13K reduced ROS generation stimulated by LPS in HaCaT cells (Fig. (Fig.4c).4c). LPS was used in this study to simulate the acidic stress caused by the bacterial infection’s local overactive inflammatory response. According to q-PCR results, HAMA/tFNA-GL13K could reduce the expression of inflammatory factors IL-1b, TNF-a, and IL-6 induced by LPS, whereas HAMA/GL13K had no regulatory effect on the expression of the forementioned inflammatory factors under the same conditions (Fig. (Fig.4d4d).

HAMA/tFNA-GL13K facilitates skin infected wound healing in vivo

The healing effect of the hydrogels was evaluated in vivo by capturing and analyzing the wound area. Figure Figure5b5b demonstrated wound representative images afterward S. aureus and E. coli infection on days 0, 3, 5, 7, 10, and 14. The wound area was analyzed on the 7th and 14th day after surgery, and there was almost no difference between the HAMA group and the control group. The areas of the HAMA/tFNA and HAMA/ GL13K groups were smaller than that of the control group, with the HAMA/tFNA-GL13K group showing the smallest area (Fig. (Fig.5c).5c). The relevant wound closure ratio in infected mice is shown in Fig. Fig.5d.5d. The Two-Way ANOVA analysis revealed significant differences between the groups. The wound healing rate of HAMA/tFNA-GL13K hydrogel after 14 days of treatment was 97.83 1.566%, assessed as the most effective therapeutic impact among the groups.

An external file that holds a picture, illustration, etc.
Object name is 41368_2024_290_Fig5_HTML.jpg

Evaluation of HAMA/tFNA-GL13K hydrogel in vivo for skin repair and wound healing in general observation. a Flow chart of the experiment in vivo. b Representative images of the wound healing process in 5 groups at the indicated time point. c Wound area of 5 groups on the 7th and 14th day. Superscripts ac indicating significant differences (P < 0.05). d Wound healing rate of diverse groups (P < 0.000 1, ****)

Histological analysis was used to assess the quality of the regenerated tissue in each group (Fig. 6a–e). On 7th day, HE and MASSON-stained sections revealed that the HAMA/tFNA-GL13K group had the least inflammatory cell infiltration and the most collagen fiber deposition in the dermal tissue (Fig. (Fig.6a).6a). The Area of unhealed wound in the HAMA/tFNA-GL13K groups decreased significantly compared to the control and other groups on the 14th day (Fig. (Fig.6c,6c, P < 0.05). Furthermore, on the 14th day, the epithelial thickness of the HAMA/tFNA and HAMA/tFNA-GL13K groups was not significantly different from that of healthy skin, whereas the epithelial thickness of the other groups remained thinner (Fig. (Fig.6d).6d). On the 14th day, Masson staining revealed that collagen fibers were deposited in the dermal tissue of the HAMA/tFNA-GL13K group, but barely deposited in the wound site of the HAMA/GL13K group, which was not conducive to wound healing. However, collagen fibers were deposited in large quantities in the control and HAMA groups, resulting in scarring (Fig. (Fig.6e,6e, P < 0.05). Despite the fact that both the control and HAMA groups formed the fundamental epithelium and dermal structure, mild inflammatory response during the dermis repair process can be observed.

An external file that holds a picture, illustration, etc.
Object name is 41368_2024_290_Fig6_HTML.jpg

Evaluation of HAMA/tFNA-GL13K hydrogel in vivo for skin repair and wound healing in microscopic observation. a Images of wound tissue after H&E and Masson staining on the 7th day. Scale bars = 200 μm. b Images of wound tissue after H&E and Masson staining on the 14th day. Scale bars = 4 mm (black) and 200 μm (white) (The unhealed area was denoted by black and white dotted lines). c Quantitative analysis of the unhealed dermis area in five groups. d Quantitative analysis of epidermal thickness in five groups. e Quantitative analysis of collagen volume fraction. Superscripts ad indicating significant differences (P < 0.05). Data are presented as the mean ± SD (n = 3). T-GL13K is the abbreviation of tFNA-GL13K

Discussion

Wound healing consists of sequential, overlaid stages of hemostasis, inflammation, proliferative and remodeling phases.37 And the bacteria and excessive inflammation are two main causes of wound delayed-healing.38 Keratinocytes basically run through the whole process of skin repair by releasing inflammatory cytokines, self-migrate, and secreting growth factors, which promote proliferation of other skin cells.39 Thus, wound treatment strategies that prevent both bacterial infection and bacterial- products-induced excessive inflammation are critically required. An ideal wound dressing material needs to combine antibacterial properties, anti-inflammatory properties, promote healing and inhibit scarring simultaneously.40 In this study, 1% HAMA hydrogel was used as a delivery system to load the tFNA-GL13K complex, and the wound healing effect of HAMA/tFNA-GL13K hydrogel on infected full-thickness skin was investigated.

TFNAs have been proven to have beneficial properties including promoting cell migration, regulating immunity, inhibiting scarring, and promoting the proliferation of various cells, indicating that it might serve as drug candidates for skin defect wound healing.30,36,4144 Meanwhile, tFNAs have shown to be an excellent carrier, with the ability to carry aptamers, such as siRNA, miRNA, antibiotics, and antimicrobial peptides, showing its wide range of applications.25,4549 A tetrahedral framework DNA-based bioswitchable miRNA inhibitor delivery system has shown superior skin penetration and RNA delivery ability.50 Inspired by this, we initially incubated GL13K on tFNAs to investigate whether this alters their beneficial properties and to elucidate the impact of tFNA-GL13K on the fundamental functions of HaCaT cells. This was achieved through a systematic evaluation of their biological activity, including drug distribution, proliferation, migration, and anti-inflammatory activity, in order to functionally characterize tFNA-GL13K. It was found that, GL13K can promote the attachment of tFNAs to HaCaT cells in the drug distribution experiment, which can result from that GL13K possessing a positive charge and consequently readily interacting with the cell membrane. When exposed to LPS, tFNA-GL13K showed the ability to mitigate cytotoxicity, enhance migration of HaCaT cells, scavenge ROS, and suppress the expression of inflammatory factors. Notably, the effects of tFNA-GL13K were found to be superior to those of GL13K and tFNAs individually. When combined with tFNAs, tFNAs-GL13K primarily exhibits the physiological properties of tFNAs on tissue growth cells, the complex’s cytotoxicity is reduced, and it can promote cell migration. In the in vivo experiment, the biosafety of the hydrogel was confirmed, and no obvious abnormalities were found in the slices of the five internal organs (Appendix Fig. 3). Excessive ROS production can cause harmful processes such as inflammation and necrosis, which can delay skin wound healing and tissue regeneration.51 By regulating Keap/SOD2 signaling, tFNAs can decrease the generation of intracellular reactive oxygen species (ROS) and protect against oxidative stress,52 which is consistent with our result. Inflammatory factors IL-1β and TNF-α are important inflammatory response markers that, when overexpressed, inhibit wound healing.53 Materials loaded tetrahedral framework nucleic acids have been shown in previous studies to reduce the expression of LPS-induced inflammatory factors of the macrophages and RAW264.7 cells.5456 Similarly, HAMA/tFNA-GL13K can down-regulate the expression of inflammatory factors (IL-1β, IL-6, and TNF-α) in HaCaT cells induced by LPS in this study. TFNA-GL13K in the composite hydrogel successfully accelerated the healing of bacterially infected wounds in vivo, as expected. Furthermore, by appropriately promoting collagen deposition to reduce scar formation, and the thickness of the newly formed epithelium is close to that of healthy skin. In previous research, subcutaneous injection of tFNAs was used to treat non-infectious wounds, and the gross appearance and tissue sections essentially represented scarless wound healing on the 21st day.36 Nevertheless, by the 14th day of this study, the HAMA/tFNA-GL13K hydrogel group had visible healing, indicating that the presence of hydrogel and antimicrobial peptides aids tFNAs in exerting its biological properties. The Masson staining results revealed that, while the surgical procedure and Infection of bacteria caused skin fibrosis, the use of HAMA/tFNA-GL13K decreased the rate of skin fibrosis.

Controlling bacteria in infected wound healing is also essential. tFNAs as a carrier, can enhance the stability of GL13K and carried GL13K to interact with Gram-positive and Gram-negative bacteria. The combination of the antimicrobial peptide GL13K with tFNAs could increase bacterial uptake, enhance interactions with microbial membranes and decrease susceptibility to the protease-dense extracellular environment of GL13K.25 This effect is attributed to the potential shielding properties of tFNAs, which, as hollow nanomaterials with potential accommodations, are believed to reduce the interaction between the drug and the protease.57 Therefore, tFNA-GL13K has more sustainable and stable antibacterial action than GL13K. The most typical pathogenic bacterial isolates in skin infections are S. aureus and E. coli, which are also relatively representative Gram-positive and Gram-negative bacteria.58 The loading ratio of tFNAs and GL13K selected in this experiment is 1:500, which is also consistent with the optimal ratio reported in previous research.25 In contrast to alternative AMP delivery approaches, tFNA not only enhances the stability and antibacterial efficacy of GL13K but also exhibits superior biological properties capable of concurrently regulating inflammation and facilitating wound healing. In the context of scarless healing, the efficacy appears to be attributed to the tFNAs, which are in line with previous studies.36 In the in vitro antibacterial experiment portion of this study, HAMA/tFNA-GL13K outperformed HAMA/GL13K against both Gram-negative and Gram-positive bacteria. The encapsulation and sustained release of hydrogels/tFNA delivery nanocarriers represent a valuable approach for enhancing the strength, stability, and protection of peptides against enzymatic degradation.

Additionally, these dressings should have good vapor permeability, effectively remove wound exudates, and cover wounds of different shapes.59 Polymeric hydrogels, with good hydrophilicity, outstanding biocompatibility, and adaptable physical properties, are among the most potential wound dressing material candidates.60 The particular physicochemical properties of hydrogels enable the preservation of nucleic acid biological activity, as well as the retention and continuous release of nucleic acid as local delivery carriers.61 As one of the most frequently utilized polymeric hydrogels, the loose and multiporous network structure of HAMA promotes cell adhesion and migration, keeps the surrounding tissue moist, absorbs wound exudate, and speeds up wound healing, which has been extensively applied in the treatment of skin, joint, and the nervous system diseases as advanced nano-carrier.6264 Hyaluronic acid is crucial element of the extracellular matrix in human tissues, endowing it with outstanding biocompatibility and non-immunogenicity. It plays a role in regulating cell behavior, including the promotion of cell proliferation and migration. Additionally, hyaluronic acid undergoes rapid biodegradation in the body, generating non-toxic degradation products.65,66 Excellent physical and chemical properties of hydrogel also aid in infected wound healing. In our study, the injectable property of HAMA/tFNA-GL13K hydrogel was investigated, as shown in Appendix Fig. 1a. The optical images demonstrate that the hydrogel can be sucked into a 1 ml syringe under solution conditions with a 26 G needle tip, then injected into the formula shape at room temperature and cured by UV light curing. As a result, hydrogels can be applied to irregularly shaped wounds to isolate the tissue deficiencies from the surrounding environment, reducing the risk of wound infection. According to rheological experiments, HAMA/tFNA-GL13K hydrogel has a superior elasticity and moderate viscosity. Therefore, when applied to skin wounds with high flexibility, it can be well fixed and recovered (Appendix Fig. 1b).

In summary, we successfully synthesized a hydrogel HAMA/tFNA-GL13K with composite nanoparticles. Firstly, it has been demonstrated that tFNA-GL13K had broad-spectrum antibacterial properties, promoting cell migration, and inhibited scar formation in vitro and in vivo, outperforming tFNAs and GL13K. We then used HAMA/tFNA-GL13K hydrogel to treat infected skin full-thickness defect wounds to further validate the application model of tFNA-GL13K in disease. The findings indicate that HAMA/tFNA-GL13K hydrogel can effectively promote wound healing and reduce scarring. Moreover, the tFNA-based delivery system could be more broadly applied to other kinds of protease-sensitive materials. In addition, small molecules such as aptamers and miRNAs can be linked to the side arms of tFNA-GL13K to enhance its proangiogenic and anti-inflammatory properties. Overall, the newly prepared nanoparticle hydrogel has excellent antibacterial efficacy and can effectively treat skin-infected wounds by promoting cell migration and inhibiting the massive production of ROS and the overexpression of inflammatory factors, thereby providing new insights into treatment approaches to other bacterial infectious diseases. TFNA-based hydrogels can be utilized in the fabrication of organoid tissue engineering scaffolds.

Materials and methods

Bacterial strains and growth conditions

E. coli strain (ATCC 8739) and S. aureus strain (ATCC 6538) were obtained from the State Key Laboratory of Oral Diseases (Sichuan University, Chengdu, China). E. coli and S. aureus were routinely cultured LB broth or on LB agar plates (Solarbio) at 37 °C.

Cell culture

Mingjing Biology (Shanghai, China) provided the HaCaT cell lines, and the cells were cultured in Roswell Park Memorial Institute (RPMI) medium containing 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) penicillin-streptomycin in an incubator under controlled conditions (37 °C, 5% CO2).

Preparation and characterization of HAMA/tFNA-GL13K hydrogel

Equimolar concentrations of 4 DNA single strands were added in the TM buffer containing 10 mmol/L Tris-HCl and 50 mM MgCl2•6H2O (pH 8.0). The mixture was then denatured at 95 °C (10 min) and maintained at 4 °C (20 min) to synthesize tFNA as previously reported. GL13K and tFNA were mixed, and incubated for 30 min at room temperature, then kept at 4 °C overnight to form t-GL13K.25

To verify tFNA and t-GL13K, 8% PAGE was performed to measure the approximate relative molecular weights of four ssDNAs, tFNA, and t-GL13K. TEM (Tecnai G2 F20, FEI, America) and AFM (Shimadzu, Kyoto, Japan) were used for morphological observation of tFNA and t-GL13K. The hydrodynamic diameters and zeta potentials of the particles were quantified applying DLS on a Zeta sizer Nano (ZS90, Malvern, UK).

The HAMA/tFNA-GL13K hydrogel was prepared based on HAMA (Aladdin, H398341), photo-initiator LAP, and t-GL13K. In brief, tFNA, GL13K, and t-GL13K (250 nmol/L) were added after a predefined amount of HAMA (1 wt% of the solvent mass) and LAP (0.1 wt% of the solvent mass) were dissolved in the PBS. The hydrogel was cured below the UV light source (wavelength 365 nm, intensity 18 mW/cm2) via cross-linking for 30 s to 1 min before use. Hydrogels were soaked in phosphate-buffered saline (PBS), and the soak solution was collected and filtered through 0.22-μm Minisart® NML syringe filters as test agents for bacteriologic and cytological tests.

The hydrogels were swiftly frozen in a refrigerator set to −80 °C, and after that, they were vacuum-dried for 24 h at −50 °C. Following their freeze-drying, the hydrogels were sprayed with gold after being quenched in liquid nitrogen along a cross-section. The rheological properties of hydrogels were measured by using Anton Paar MCR102 rheometer (Anton Paar, MCR102, Germany) with a cone plate system (diameter, 35 mm; angle, 2°). The range of angular velocity was from 0.01 to 100 rad/s under room temperature. The chemical composition of the hydrogels was determined using attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR, Nicolet iS50, Thermo Scientific, Waltham, MA, USA) analysis. Freeze-dried samples were placed on the attenuated total reflectance (ATR) crystal of a Bruker Alpha-P, 64 scans were recorded for each spectrum at a resolution of 4.0 cm−1, and the data between 4000 and 400 cm–1 were saved.

In vitro antimicrobial activity assay

200 μL of hydrogel was loaded onto a 12-well plate and exposed to UV light for 30 s. 1 mL of S. aureus and E. coli suspension (1 × 105 CFU per mL) was added to the hydrogel-coated 12-well plate and cultured for 12 h. The bacterial suspension is diluted 1 000 times, LB agar plates were filled with 20 μL of the forementioned bacterial solution and left at 37 °C for 24 hours. The colony forming unit (CFU) of the plates was measured and determined.67

S. aureus and E. coli cultures were adjusted to 1 × 105 CFU per mL after overnight (16 h) incubation. Bacteria were collected by centrifugation (4 000 × g, 4 °C, 10 min) and incubated in LB culture containing test agents at 37 °C for 10 h. Spectrophotometer (UV1601, Shimadzu, Japan) was applied to measure the OD600 nm value per hour for 10 hours. This experiment was repeated at least three times using triplicate samples at each time point.

Distribution of Cy5 and FITC-loaded t-GL13K in HaCaT cells

Flow cytometry and immunofluorescence assays were used to examine the distribution of tFNA, GL13K, and t-GL13K complex in HaCaT cells. Firstly, HaCaT cells were seeded in the six-well plates (2 × 105 per well). After 24 h of culture in standard medium, RPMI culture with 2% FBS replaced the standard medium, and LPS (10 μg/mL) was added to simulate the microenvironment of bacterial infection. After 1 h, soak solution of hydrogels with FITC-loaded GL13K, Cy5-loaded tFNA (250 nmol/L), or FITC&Cy5-loaded t-GL13K (250 nmol/L) was added. Following a 6-hour incubation period, the cells were extracted. To evaluate the distribution of tFNA, GL13K, and t-GL13K complex’s cell, flow cytometry was used.68 Following 6 h of treatment, the cell samples were fixed for at least 30 min in 4% (w/v) paraformaldehyde solution (Boster, Wuhan, China). TRITC- Phalloidin and DAPI (4′6-diamidino-2-phenylindole) (Sigma, St. Louis, MO) were applied for the cytoskeleton and nucleus staining respectively. Cytoskeleton staining was performed for 30 min and the nucleus staining for 10 min. Following every phase, all cell samples were washed three times with PBS. Ultimately, the stained samples were observed via a confocal laser microscope (Nikon N-SIM, Tokyo, Japan).36

In vitro cytotoxicity assay

The cytotoxicity of the samples was measured by applying the CCK-8 assay (KeyGEN, Jiangsu, China). A 96-well plate containing roughly 8 000 Hacat cells per well was utilized for CCK-8. Cultured the cells overnight, the medium was shifted to RPMI containing 2% (v/v) FBS and 10 μg/mL LPS, and tFNA with GL13K of different concentrations was added 1 h later. The cell medium of control group was devoid of tFNA. The assessment of cytotoxicity was conducted following treatments with CCK-8 solution for 6 h, 12 h, and 24 h. The absorbance of each well was quantified at a wavelength of 450 nm relative to a blank sample consisting of RPMI medium.

Cell wound scratch assay

The behavior of cell migration was examined through scratch experiments. HaCaT cells (2 × 105) were seeded in 12-well plate and left to culture overnight. Each well was cross-hatched with a pipette tip after being cleaned with PBS. After rewashing three times, the cells were cultured in RPMI medium containing 2% (v/v) FBS and 10 μg/mL LPS, and varying soak solution mentioned above was added 1 h later. After 4, 8, 12, and 24 h of treatment, pictures of the samples were captured. The measurements of the scratch areas were conducted, documented, and subsequently compared to the initial scratch sizes at 0 hours using Image-J software.

Measurement of ROS

The extent of intracellular reactive oxygen species (ROS) was detected using DCF staining and conducted by flow cytometry. DCFH-DA exhibits cell permeability, and DCF is a fluorescent material decomposed from intracellular DCFH-DA. A 96-well plate containing roughly 8 000 HaCaT cells per well was utilized for measurement of ROS. Cultured the cells overnight, the medium was altered to RPMI containing 2%(v/v) FBS and 10 μg/ml LPS, and soak solution of different hydrogels was added 1 h later. After treated with soak solution of hydrogels for 6 h, DCFH-DA was diluted with serum-free medium and added to the cell suspension and incubated for 30 min at 37 °C in the dark. Then the cells were collected and washed three times with PBS, and flow cytometry was used to measure the DCF in cells.69

RNA isolation and quantitative reverse transcription-polymerase chain reaction (qRT-PCR)

HaCaT cells (2 × 105) were seeded in 6-well plate and left to culture overnight. The cells were cultured in RPMI medium containing 2% (v/v) FBS and 10 μg/mL LPS, and varying soak solution mentioned above was added 1 hour later. After being treated for 6 h, RNA of HaCaT cells was isolated and purified with TriZol Reagent (Invitrogen) and chloroform. Reverse transcription of RNA into cDNA was performed with the cDNA synthesis kit (PrimeScript RT reagent kit, Takara, Japan), and then expression of genes encoding inflammatory-related factors, including TNF-α, IL-1β, IL-6, and p65(encoding genes were named as TNF-α, IL-1β, IL-6, and p65, respectively) was determined using a SYBR Green qPCR kit (Takara, Dalian, China) according to the manufacturer’s instructions and a previously described method,70 with the GADPH as internal control. (The primer sequences are displayed in Appendix Table 1). The 2−ΔΔCT method was applied for relative quantitative analysis.

Establishment of in vivo infected skin model

The modeling of full-thickness skin infected wounds in mice was executed following established protocols.71 Briefly, the mice were anesthetized and positioned on the surgical plate. After using electric scissors and depilatory wax to shave the back hair, each mouse had a full-thickness and round wound (diameter 10 mm) made on its back with a biopsy punch. 10 μL S. aureus and E. coli of each was instilled on the exposed wound to establish an infected wound. The mice were allocated into 5 groups in a randomized method, with 6 mice in each group. From the next day, all hydrogels were applied locally to the site of the wound every two days. The wound was tracked and photographed on days 0, 3, 5, 7, 10, and 14 following surgery. Half of the mice were subjected to euthanasia on the 7th and 14th days following the surgical procedure, and the wound area along with surrounding tissues were promptly gathered for subsequent analysis. And the heart, liver, spleen, lung, and kidney were dissected for biosafety test.

Histological analysis

Following fixation for 1 h in 4% paraformaldehyde, the skin and internal organ tissues were embedded in paraffin, and then sliced into 4 μm sections and stained with either the Masson Staining Kit or the Hematoxylin-Eosin (HE) Staining Kit. Subsequently, the stained tissue sections were imaged by applying an FSX100 microscope (Olympus, Tokyo, Japan). The area of the unhealed wound, the thickness of the epithelium, and the percentage of fibration of each sample were determined by measuring and averaging three distinct visual fields of each section.

Statistical analysis

Statistical tests were conducted using GraphPad Prism 9.0. The differences among groups were analyzed via the one-way ANOVA, two-way ANOVA, and Student’s t-test P-value < 0.05 was set to indicate statistical significance.

Supplementary information

Acknowledgements

This study was supported by National Key R&D Program of China (2019YFA0110600), National Natural Science Foundation of China (82370929, 81970916), Sichuan Science and Technology Program (2022NSFSC0002), Sichuan Province Youth Science and Technology Innovation Team (2022JDTD0021), Research and Develop Program, West China Hospital of Stomatology Sichuan University (RD03202302). We would like to thank Liying Hao (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) for help in characterizing AFM. We acknowledge the support of the State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Oral & Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University.

Author contributions

C.Q. and Q.S. contributed equally to this work. Y.F.L., B. G., Q.S., and C.Q. designed the research. C.Q. and Q.S. performed most of the experiments and wrote the manuscript. D.X.X., M.Z., and S.G. helped with project design and provided guidance on some experiments. All authors read and approved the final manuscript.

Competing interests

The authors declare no competing interests.

Ethics approval

All animal experiments in this study followed the Helsinki Declaration and all animal protocols were approved by the Ethics Committee of West China Hospital of Stomatology, Sichuan University, as well as the Guide for the Care and Use of Laboratory Animals and the ARRIVE guidelines.

Footnotes

These authors contributed equally: Cai Qi, Qiang Sun

Contributor Information

Bin Guo, moc.621@8040niboug.

Yunfeng Lin, nc.ude.ucs@nilgnefnuy.

Supplementary information

The online version contains supplementary material available at 10.1038/s41368-024-00290-3.

References

1. Guo HQ, et al. Epidemiology of maxillofacial soft tissue injuries in an oral emergency department in Beijing: a two-year retrospective study. Dent. Traumatol. 2021;37:479–487. 10.1111/edt.12655. [Abstract] [CrossRef] [Google Scholar]
2. Zhou J, et al. Oral and maxillofacial emergencies: A retrospective study of 5220 cases in West China. Dent. Traumatol. 2023;39:140–146. 10.1111/edt.12798. [Abstract] [CrossRef] [Google Scholar]
3. Guo HQ, Yang X, Wang XT, Ji AP, Bai J. Risk Factors for Infection of Sutured Maxillofacial Soft Tissue Injuries. Surg. Infect. (Larchmt.) 2022;23:298–303. 10.1089/sur.2021.358. [Abstract] [CrossRef] [Google Scholar]
4. Percival SL, et al. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen. 2012;20:647–657. 10.1111/j.1524-475X.2012.00836.x. [Abstract] [CrossRef] [Google Scholar]
5. Prompers L, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50:18–25. 10.1007/s00125-006-0491-1. [Abstract] [CrossRef] [Google Scholar]
6. Juhasz MLW, Cohen JL. Microneedling for the treatment of scars: an update for clinicians. Clin. Cosmet. Investig. Dermatol. 2020;13:997–1003. 10.2147/CCID.S267192. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
7. Deflorin C, et al. Physical management of scar tissue: a systematic review and meta-analysis. J. Alter. Complement Med. 2020;26:854–865. 10.1089/acm.2020.0109. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
8. Lee MR, Paver R. Prophylactic antibiotics in dermatological surgery. Australas. J. Dermatol. 2016;57:83–91. 10.1111/ajd.12312. [Abstract] [CrossRef] [Google Scholar]
9. Ciofu O, Moser C, Jensen PO, Hoiby N. Tolerance and resistance of microbial biofilms. Nat. Rev. Microbiol. 2022;20:621–635. 10.1038/s41579-022-00682-4. [Abstract] [CrossRef] [Google Scholar]
10. Kalelkar PP, Riddick M, Garcia AJ. Biomaterial-based delivery of antimicrobial therapies for the treatment of bacterial infections. Nat. Rev. Mater. 2022;7:39–54. 10.1038/s41578-021-00362-4. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
11. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA. Hydrogels in regenerative medicine. Adv. Mater. 2009;21:3307–3329. 10.1002/adma.200802106. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
12. Eke G, Mangir N, Hasirci N, MacNeil S, Hasirci V. Development of a UV crosslinked biodegradable hydrogel containing adipose derived stem cells to promote vascularization for skin wounds and tissue engineering. Biomaterials. 2017;129:188–198. 10.1016/j.biomaterials.2017.03.021. [Abstract] [CrossRef] [Google Scholar]
13. Li Y, et al. Hyaluronic acid-methacrylic anhydride/polyhexamethylene biguanide hybrid hydrogel with antibacterial and proangiogenic functions for diabetic wound repair. Chin. Chem. Lett. 2022;33:5030–5034. 10.1016/j.cclet.2022.03.116. [CrossRef] [Google Scholar]
14. Maloney FP, et al. Structure, substrate recognition and initiation of hyaluronan synthase. Nature. 2022;604:195–201. 10.1038/s41586-022-04534-2. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
15. Khetan S, et al. Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels. Nat. Mater. 2013;12:458–465. 10.1038/nmat3586. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
16. Mookherjee N, Anderson MA, Haagsman HP, Davidson DJ. Antimicrobial host defence peptides: functions and clinical potential. Nat. Rev. Drug Discov. 2020;19:311–332. 10.1038/s41573-019-0058-8. [Abstract] [CrossRef] [Google Scholar]
17. Schneider VA, et al. Imaging the antimicrobial mechanism(s) of cathelicidin-2. Sci. Rep. 2016;6:32948. 10.1038/srep32948. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
18. Hancock RE, Haney EF, Gill EE. The immunology of host defence peptides: beyond antimicrobial activity. Nat. Rev. Immunol. 2016;16:321–334. 10.1038/nri.2016.29. [Abstract] [CrossRef] [Google Scholar]
19. van der Does AM, Hiemstra PS, Mookherjee N. Antimicrobial host defence peptides: immunomodulatory functions and translational prospects. Adv. Exp. Med. Biol. 2019;1117:149–171. 10.1007/978-981-13-3588-4_10. [Abstract] [CrossRef] [Google Scholar]
20. Pezzulo AA, et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature. 2012;487:109–113. 10.1038/nature11130. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
21. Mallia P, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012;186:1117–1124. 10.1164/rccm.201205-0806OC. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
22. Pachon-Ibanez ME, Smani Y, Pachon J, Sanchez-Cespedes J. Perspectives for clinical use of engineered human host defense antimicrobial peptides. FEMS Microbiol. Rev. 2017;41:323–342. 10.1093/femsre/fux012. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
23. Harmouche N, et al. Solution and solid-state nuclear magnetic resonance structural investigations of the antimicrobial designer peptide GL13K in membranes. Biochemistry. 2017;56:4269–4278. 10.1021/acs.biochem.7b00526. [Abstract] [CrossRef] [Google Scholar]
24. Li T, et al. Antibacterial activity and cytocompatibility of an implant coating consisting of TiO(2) nanotubes combined with a GL13K antimicrobial peptide. Int J. Nanomed. 2017;12:2995–3007. 10.2147/IJN.S128775. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
25. Liu Y, et al. Tetrahedral framework nucleic acids deliver antimicrobial peptides with improved effects and less susceptibility to bacterial degradation. Nano Lett. 2020;20:3602–3610. 10.1021/acs.nanolett.0c00529. [Abstract] [CrossRef] [Google Scholar]
26. Gera S, Kankuri E, Kogermann K. Antimicrobial peptides–unleashing their therapeutic potential using nanotechnology. Pharmacol. Ther. 2022;232:107990. 10.1016/j.pharmthera.2021.107990. [Abstract] [CrossRef] [Google Scholar]
27. Rajchakit U, et al. Size-controlled synthesis of gold nanoparticles tethering antimicrobial peptides with potent broad-spectrum antimicrobial and antibiofilm activities. Mol. Pharm. 2024;21:596–608. 10.1021/acs.molpharmaceut.3c00734. [Abstract] [CrossRef] [Google Scholar]
28. Maisetta G, Brancatisano FL, Esin S, Campa M, Batoni G. Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-beta-defensin 3 and affect peptide’s antibacterial activity in vitro. Peptides. 2011;32:1073–1077. 10.1016/j.peptides.2011.02.003. [Abstract] [CrossRef] [Google Scholar]
29. Li S, Tian T, Zhang T, Cai X, Lin Y. Advances in biological applications of self-assembled DNA tetrahedral nanostructures. Mater. Today. 2019;24:57–68. 10.1016/j.mattod.2018.08.002. [CrossRef] [Google Scholar]
30. Zhang T, Tian T, Lin Y. Functionalizing framework nucleic-acid-based nanostructures for biomedical application. Adv. Mater. 2022;34:e2107820. 10.1002/adma.202107820. [Abstract] [CrossRef] [Google Scholar]
31. Zhang Q, et al. Anti-inflammatory and antioxidative effects of tetrahedral DNA nanostructures via the modulation of macrophage responses. ACS Appl. Mater. Interfaces. 2018;10:3421–3430. 10.1021/acsami.7b17928. [Abstract] [CrossRef] [Google Scholar]
32. Wiraja C, et al. Framework nucleic acids as programmable carrier for transdermal drug delivery. Nat. Commun. 2019;10:1147. 10.1038/s41467-019-09029-9. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
33. Tian T, et al. A dynamic DNA tetrahedron framework for active targeting. Nat. Protoc. 2023;18:1028–1055. 10.1038/s41596-022-00791-7. [Abstract] [CrossRef] [Google Scholar]
34. Tian T, Li Y, Lin Y. Prospects and challenges of dynamic DNA nanostructures in biomedical applications. Bone Res. 2022;10:40. 10.1038/s41413-022-00212-1. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
35. Zhang B, et al. Facilitating in situ tumor imaging with a tetrahedral DNA framework‐enhanced hybridization chain reaction probe. Adv. Funct. Mater. 2022;32:2109728. 10.1002/adfm.202109728. [CrossRef] [Google Scholar]
36. Zhu J, et al. Tetrahedral framework nucleic acids promote scarless healing of cutaneous wounds via the AKT-signaling pathway. Signal Transduct. Target Ther. 2020;5:120. 10.1038/s41392-020-0173-3. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
37. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci. Transl. Med. 2014;6:265sr266–265sr266. 10.1126/scitranslmed.3009337. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
38. Meng Y, et al. Reactive metal boride nanoparticles trap lipopolysaccharide and peptidoglycan for bacteria-infected wound healing. Nat. Commun. 2022;13:7353. 10.1038/s41467-022-35050-6. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
39. Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound healing: a cellular perspective. Physiol. Rev. 2019;99:665–706. 10.1152/physrev.00067.2017. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
40. Kharaziha M, Baidya A, Annabi N. Rational design of immunomodulatory hydrogels for chronic wound healing. Adv. Mater. 2021;33:e2100176. 10.1002/adma.202100176. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
41. Chen Y, et al. DNA framework signal amplification platform-based high-throughput systemic immune monitoring. Signal Transduct. Target. Ther. 2024;9:28. 10.1038/s41392-024-01736-0. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
42. Zhang T, et al. nanomaterials targeting toll‐like receptor 4 prevent bisphosphonate‐related osteonecrosis of the jaw via regulating mitochondrial homeostasis in macrophages. Adv. Funct. Mater. 2023;33:2213401. 10.1002/adfm.202213401. [CrossRef] [Google Scholar]
43. Zhang T, et al. Myelosuppression alleviation and hematopoietic regeneration by tetrahedral‐framework nucleic‐acid nanostructures functionalized with osteogenic growth peptide. Adv. Sci. 2022;9:2202058. 10.1002/advs.202202058. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
44. Wang Y, et al. Tetrahedral framework nucleic acids can alleviate taurocholate-induced severe acute pancreatitis and its subsequent multiorgan injury in mice. Nano Lett. 2022;22:1759–1768. 10.1021/acs.nanolett.1c05003. [Abstract] [CrossRef] [Google Scholar]
45. Zhang T, et al. Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment. Nat. Protoc. 2020;15:2728–2757. 10.1038/s41596-020-0355-z. [Abstract] [CrossRef] [Google Scholar]
46. Li J, et al. Repair of infected bone defect with clindamycin-tetrahedral DNA nanostructure complex-loaded 3D bioprinted hybrid scaffold. Chem. Eng. J. 2022;435:134855. 10.1016/j.cej.2022.134855. [CrossRef] [Google Scholar]
47. Qin X, et al. Tetrahedral framework nucleic acids-based delivery of microRNA-155 inhibits choroidal neovascularization by regulating the polarization of macrophages. Bioact. Mater. 2022;14:134–144. [Europe PMC free article] [Abstract] [Google Scholar]
48. Gao Y, et al. A lysosome‐activated tetrahedral Nanobox for encapsulated siRNA delivery. Adv. Mater. 2022;34:2201731. 10.1002/adma.202201731. [Abstract] [CrossRef] [Google Scholar]
49. Ma W, et al. Biomimetic nanoerythrosome‐coated aptamer–DNA tetrahedron/maytansine conjugates: pH‐responsive and targeted cytotoxicity for HER2‐positive breast cancer. Adv. Mater. 2022;34:2109609. 10.1002/adma.202109609. [Abstract] [CrossRef] [Google Scholar]
50. Li S, et al. A tetrahedral framework DNA‐based bioswitchable miRNA inhibitor delivery system: application to skin anti‐aging. Adv. Mater. 2022;34:2204287. 10.1002/adma.202204287. [Abstract] [CrossRef] [Google Scholar]
51. Blaser H, Dostert C, Mak TW, Brenner D. TNF and ROS Crosstalk in Inflammation. Trends Cell Biol. 2016;26:249–261. 10.1016/j.tcb.2015.12.002. [Abstract] [CrossRef] [Google Scholar]
52. Yan R, et al. Typhaneoside-tetrahedral framework nucleic acids system: mitochondrial recovery and antioxidation for acute kidney injury treatment. ACS nano. 2023;17:8767–8781. 10.1021/acsnano.3c02102. [Abstract] [CrossRef] [Google Scholar]
53. Wang Y, et al. The role of IL-1beta and TNF-alpha in intervertebral disc degeneration. Biomed. Pharmacother. 2020;131:110660. 10.1016/j.biopha.2020.110660. [Abstract] [CrossRef] [Google Scholar]
54. Wang, Q. et al. Modulation of cerebrospinal fluid dysregulation via a SPAK and OSR1 targeted framework nucleic acid in hydrocephalus. Adv. Sci.10.1002/advs.202306622 (2024). [Europe PMC free article] [Abstract]
55. Zhang M, et al. Anti-inflammatory activity of curcumin-loaded tetrahedral framework nucleic acids on acute gouty arthritis. Bioact. Mater. 2022;8:368–380. [Europe PMC free article] [Abstract] [Google Scholar]
56. Li J, et al. Modulation of the crosstalk between Schwann cells and macrophages for nerve regeneration: a therapeutic strategy based on a multifunctional tetrahedral framework nucleic acids system. Adv. Mater. 2022;34:2202513. 10.1002/adma.202202513. [Abstract] [CrossRef] [Google Scholar]
57. Liu J, et al. A DNA-based nanocarrier for efficient gene delivery and combined cancer therapy. Nano Lett. 2018;18:3328–3334. 10.1021/acs.nanolett.7b04812. [Abstract] [CrossRef] [Google Scholar]
58. Guan H, et al. Distribution and antibiotic resistance patterns of pathogenic bacteria in patients with chronic cutaneous wounds in China. Front Med. (Lausanne) 2021;8:609584. 10.3389/fmed.2021.609584. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
59. Kaur G, Narayanan G, Garg D, Sachdev A, Matai I. Biomaterials-based regenerative strategies for skin tissue wound healing. ACS Appl. Bio. Mater. 2022;5:2069–2106. 10.1021/acsabm.2c00035. [Abstract] [CrossRef] [Google Scholar]
60. Ju Y, Hu Y, Yang P, Xie X, Fang B. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration. Mater. Today Bio. 2023;18:100522. 10.1016/j.mtbio.2022.100522. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
61. Zhong R, et al. Hydrogels for RNA delivery. Nat. Mater. 2023;22:818–831. 10.1038/s41563-023-01472-w. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
62. Ma K, et al. Application of robotic-assisted in situ 3D printing in cartilage regeneration with HAMA hydrogel: an in vivo study. J. Adv. Res. 2020;23:123–132. 10.1016/j.jare.2020.01.010. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
63. Liu N, et al. Construction of multifunctional hydrogel with metal-polyphenol capsules for infected full-thickness skin wound healing. Bioact. Mater. 2023;24:69–80. [Europe PMC free article] [Abstract] [Google Scholar]
64. Zhan Y, Zhou Z, Chen M, Gong X. Photothermal treatment of polydopamine nanoparticles@ hyaluronic acid methacryloyl hydrogel against peripheral nerve adhesion in a rat model of sciatic nerve. Int. J. Nanomed. 2023;18:2777–2793. 10.2147/IJN.S410092. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
65. Liang Y, et al. Adhesive hemostatic conducting injectable composite hydrogels with sustained drug release and photothermal antibacterial activity to promote full‐thickness skin regeneration during wound healing. Small. 2019;15:1900046. 10.1002/smll.201900046. [Abstract] [CrossRef] [Google Scholar]
66. Li M, Liang Y, Liang Y, Pan G, Guo B. Injectable stretchable self-healing dual dynamic network hydrogel as adhesive anti-oxidant wound dressing for photothermal clearance of bacteria and promoting wound healing of MRSA infected motion wounds. Chem. Eng. J. 2022;427:132039. 10.1016/j.cej.2021.132039. [CrossRef] [Google Scholar]
67. Chiangnoon R, et al. Antibacterial hydrogel sheet dressings composed of poly (vinyl alcohol) and silver nanoparticles by electron beam irradiation. Gels. 2023;9:80. 10.3390/gels9020080. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
68. Zhang X, et al. Tetrahedral-framework nucleic acids carry small interfering RNA to downregulate toll-like receptor 2 gene expression for the treatment of sepsis. ACS Appl. Mater. Interfaces. 2022;14:6442–6452. 10.1021/acsami.1c23708. [Abstract] [CrossRef] [Google Scholar]
69. Lu X, et al. Single-atom catalysts-based catalytic ROS clearance for efficient psoriasis treatment and relapse prevention via restoring ESR1. Nat. Commun. 2023;14:6767. 10.1038/s41467-023-42477-y. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
70. Datt S, et al. Gene expression profiling of protease and non-protease genes in Trichophyton mentagrophytes isolates from dermatophytosis patients by qRT-PCR analysis. Sci. Rep. 2021;11:403. 10.1038/s41598-020-79839-1. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
71. Liu L, et al. Thermosensitive hydrogel coupled with sodium ascorbyl phosphate promotes human umbilical cord-derived mesenchymal stem cell-mediated skin wound healing in mice. Sci. Rep. 2023;13:11909. 10.1038/s41598-023-38666-w. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]

Articles from International Journal of Oral Science are provided here courtesy of Nature Publishing Group

Citations & impact 


Impact metrics

Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/162552341
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/162552341

Article citations

Funding 


Funders who supported this work.

National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (1)

National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) (1)